Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of PCBP2 mRNA | CTD | PMID:23649840 | 1,2-dichloroethane | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PCBP2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PCBP2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of PCBP2 mRNA] | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of PCBP2 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCBP2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PCBP2 mRNA | CTD | PMID:33387578 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19954255 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19954255 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of PCBP2 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of PCBP2 protein | CTD | PMID:34186270 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PCBP2 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of PCBP2 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PCBP2 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of PCBP2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of PCBP2 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to PCBP2 protein] | CTD | PMID:32406909 | arsenous acid | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PCBP2 protein | CTD | PMID:25419056 | arsenous acid | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PCBP2 mRNA | CTD | PMID:20458559 | arsenous acid | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCBP2 protein] | CTD | PMID:26598702 | benzatropine | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Benztropine results in decreased expression of PCBP2 protein | CTD | PMID:34122009 | benzo[a]pyrene | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PCBP2 mRNA and Benzo(a)pyrene results in decreased expression of PCBP2 protein | CTD | PMID:20097212 and PMID:26238291 | benzo[a]pyrene | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PCBP2 mRNA | CTD | PMID:20504355 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of PCBP2 mRNA | CTD | PMID:20678512 and PMID:33670352 | bisphenol A | affects expression | ISO | PCBP2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of PCBP2 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of PCBP2 mRNA and bisphenol A results in decreased expression of PCBP2 protein | CTD | PMID:29275510 and PMID:34186270 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PCBP2 mRNA | CTD | PMID:29097150 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PCBP2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PCBP2 mRNA and [bisphenol A co-treated with Estradiol] results in decreased expression of PCBP2 mRNA | CTD | PMID:26496021 and PMID:36041667 | Bisphenol B | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of PCBP2 protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PCBP2 mRNA | CTD | PMID:36041667 | bleomycin A2 | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PCBP2 protein | CTD | PMID:29733421 | butanal | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of PCBP2 mRNA | CTD | PMID:26079696 | cadmium dichloride | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCBP2 mRNA | CTD | PMID:19840844 | caffeine | affects phosphorylation | ISO | PCBP2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of PCBP2 protein | CTD | PMID:35688186 | carbon nanotube | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | choline | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCBP2 gene | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PCBP2 protein | CTD | PMID:29733421 | copper atom | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Copper results in increased expression of PCBP2 protein | CTD | PMID:21146535 | copper(0) | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Copper results in increased expression of PCBP2 protein | CTD | PMID:21146535 | coumarin | increases phosphorylation | ISO | PCBP2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of PCBP2 protein | CTD | PMID:35688186 | coumestrol | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of PCBP2 mRNA | CTD | PMID:19167446 | crocidolite asbestos | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of PCBP2 mRNA | CTD | PMID:19446018 | cyclosporin A | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PCBP2 mRNA | CTD | PMID:25562108 and PMID:27989131 | diarsenic trioxide | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PCBP2 protein | CTD | PMID:25419056 | diarsenic trioxide | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCBP2 protein] | CTD | PMID:26598702 | diarsenic trioxide | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PCBP2 mRNA | CTD | PMID:20458559 | dorsomorphin | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCBP2 mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PCBP2 protein | CTD | PMID:23301498 | etoposide | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PCBP2 protein | CTD | PMID:29733421 | folic acid | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCBP2 gene more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PCBP2 mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | PCBP2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of PCBP2 protein | CTD | PMID:37730182 | geldanamycin | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of PCBP2 mRNA | CTD | PMID:26705709 | hydrogen sulfide | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Hydrogen Sulfide results in decreased expression of PCBP2 protein | CTD | PMID:29932956 | ivermectin | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of PCBP2 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCBP2 gene | CTD | PMID:20938992 | methidathion | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | methidathion results in increased expression of PCBP2 mRNA | CTD | PMID:34813904 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of PCBP2 mRNA | CTD | PMID:30047161 | methylmercury chloride | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of PCBP2 mRNA | CTD | PMID:28001369 | methylparaben | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | methylparaben results in increased expression of PCBP2 mRNA | CTD | PMID:31745603 | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCBP2 mRNA more ... | CTD | PMID:19840844 | okadaic acid | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCBP2 mRNA | CTD | PMID:19840844 | paracetamol | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PCBP2 mRNA | CTD | PMID:21420995 | paracetamol | affects expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PCBP2 mRNA | CTD | PMID:17562736 | parathion | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | Parathion results in increased expression of PCBP2 mRNA | CTD | PMID:34813904 | phenylmercury acetate | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCBP2 mRNA | CTD | PMID:27188386 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Pcbp2 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCBP2 mRNA | CTD | PMID:19840844 | pirinixic acid | increases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of PCBP2 mRNA | CTD | PMID:23811191 | propanal | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of PCBP2 mRNA | CTD | PMID:26079696 | propiconazole | decreases expression | ISO | Pcbp2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of PCBP2 mRNA | CTD | PMID:21278054 | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of PCBP2 mRNA | CTD | PMID:21565894 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of PCBP2 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCBP2 mRNA | CTD | PMID:27188386 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of PCBP2 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | PCBP2 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCBP2 mRNA | CTD | PMID:26378955 | sunitinib | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of PCBP2 mRNA | CTD | PMID:31533062 | thimerosal | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PCBP2 mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Urethane results in increased expression of PCBP2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PCBP2 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PCBP2 mRNA | CTD | PMID:23179753 more ... | vorinostat | decreases expression | ISO | PCBP2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PCBP2 mRNA | CTD | PMID:27188386 | |